These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17867727)

  • 21. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    ACCESS-SMC Partnership
    Lancet; 2020 Dec; 396(10265):1829-1840. PubMed ID: 33278936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
    Faye B; Ndiaye JL; Ndiaye D; Dieng Y; Faye O; Gaye O
    Malar J; 2007 Jun; 6():80. PubMed ID: 17570848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of short-course quinine and single-dose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in Mpumalanga Province, South Africa.
    Athan E; Dürrheim DN; Barnes K; Mngomezulu NM; Mabuza A; Govere J
    S Afr Med J; 2001 Jul; 91(7):592-4. PubMed ID: 11544977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan.
    Elamin SB; Malik EM; Abdelgadir T; Khamiss AH; Mohammed MM; Ahmed ES; Adam I
    Malar J; 2005 Sep; 4():41. PubMed ID: 16162284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
    Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
    Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Sagara I; Dicko A; Djimde A; Guindo O; Kone M; Tolo Y; Thera MA; Sogoba M; Fofana M; Ouattara A; Sissoko M; Jansen HF; Doumbo OK
    Am J Trop Med Hyg; 2006 Oct; 75(4):630-6. PubMed ID: 17038684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate.
    Rwagacondo CE; Niyitegeka F; Sarushi J; Karema C; Mugisha V; Dujardin JC; Van Overmeir C; van den Ende J; D'Alessandro U
    Am J Trop Med Hyg; 2003 Jun; 68(6):743-7. PubMed ID: 12887037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.
    Matangila JR; Doua JY; Mitashi P; da Luz RI; Lutumba P; Van Geertruyden JP
    Int J Antimicrob Agents; 2017 Mar; 49(3):339-347. PubMed ID: 28108368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
    Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
    Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
    Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parenteral therapy of moderately severe malaria: comparison of intramuscular artemether and intramuscular sulfadoxine-pyrimethamine.
    Salako LA; Walker O; Sowunmi A
    Trans R Soc Trop Med Hyg; 1994; 88(1):89-91. PubMed ID: 8154016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of delayed introduction of sulfadoxine-pyrimethamine and arthemeter-lumefantrine on malaria epidemiology in KwaZulu-Natal, South Africa.
    Knight SE; Anyachebelu EJ; Geddes R; Maharaj R
    Trop Med Int Health; 2009 Sep; 14(9):1086-92. PubMed ID: 19624481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
    Lee SJ; Ter Kuile FO; Price RN; Luxemburger C; Nosten F
    PLoS One; 2017; 12(2):e0168780. PubMed ID: 28192434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacovigilance of malaria intermittent preventive treatment in infants coupled with routine immunizations in 6 African countries.
    de Sousa A; Rabarijaona LP; Tenkorang O; Inkoom E; Ravelomanantena HV; Njarasoa S; Whang JN; Ndiaye JL; Ndiaye Y; Ndiaye M; Sow D; Akadiri G; Hassan J; Dicko A; Sagara I; Kubalalika P; Mathanga D; Bizuneh K; Randriasamimanana JR; Recht J; Bjelic I; Dodoo A
    J Infect Dis; 2012 Mar; 205 Suppl 1():S82-90. PubMed ID: 22315391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.
    Assi SB; Aba YT; Yavo JC; Nguessan AF; Tchiekoi NB; San KM; Bissagnéné E; Duparc S; Lameyre V; Tanoh MA
    Malar J; 2017 Jan; 16(1):8. PubMed ID: 28049523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.
    Bakyaita N; Dorsey G; Yeka A; Banek K; Staedke SG; Kamya MR; Talisuna A; Kironde F; Nsobya S; Kilian A; Reingold A; Rosenthal PJ; Wabwire-Mangen F
    Am J Trop Med Hyg; 2005 May; 72(5):573-80. PubMed ID: 15891132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of different artemisinin-based combinations for the treatment of Plasmodium falciparum malaria in children in Kigali, Rwanda, an area of resistance to sulfadoxine-pyrimethamine: artesunate plus sulfadoxine/pyrimethamine versus artesunate plus sulfamethoxypyrazine/pyrimethamine.
    Rulisa S; Gatarayiha JP; Kabarisa T; Ndayisaba G
    Am J Trop Med Hyg; 2007 Oct; 77(4):612-6. PubMed ID: 17978058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia.
    von Seidlein L; Walraven G; Milligan PJ; Alexander N; Manneh F; Deen JL; Coleman R; Jawara M; Lindsay SW; Drakeley C; De Martin S; Olliaro P; Bennett S; Schim van der Loeff M; Okunoye K; Targett GA; McAdam KP; Doherty JF; Greenwood BM; Pinder M
    Trans R Soc Trop Med Hyg; 2003; 97(2):217-25. PubMed ID: 14584381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
    Crawley J; Sismanidis C; Goodman T; Milligan P;
    Lancet; 2012 Sep; 380(9846):1001-10. PubMed ID: 22850358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.